Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2003
05/01/2003US20030083481 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of prostate cancer
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083465 Protein for use in treatment and prevention of angiogenesis
05/01/2003US20030083303 A replicated and packaged vector construct inside a virion particle in the helper cell, able expressing a foreign gene in a mammalian cell; use in transfection
05/01/2003US20030083299 Non-invasive delivery of polypeptides through the blood-brain barrier
05/01/2003US20030083296 Antisense modulation of caspase 8 expression
05/01/2003US20030083295 An oligonucleotides are hybridizable with nucleic acids to inhibit the gene expression of enzyme
05/01/2003US20030083294 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
05/01/2003US20030083293 Drug delivery of the chromosomes comprising a heterologous DNA to selected cells and tissues; transfection, production of heterologous proteins, gene therapy, generating non-human transgenic animals
05/01/2003US20030083291 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
05/01/2003US20030083289 Herpesvirus vectors and their uses
05/01/2003US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides
05/01/2003US20030083280 Oligonucleotides which hybridize with nucleic acids which encode said protein; gene therapy; genetic engineering; for treatment of angina and myocardial infarction
05/01/2003US20030083277 Use of insulin degrading enzyme (IDE) for the treatment of alzheimer's disease in patients
05/01/2003US20030083275 Antisense oligodeoxynucleotides regulating expression of tnf alpha
05/01/2003US20030083272 Sense mrna therapy
05/01/2003US20030083257 Spliceable nucleotide sequence inserted into the wild-type factor viii cDNA at the original position of an intron of the genomic factor viii DNA; gene therapy; treatment of hemophilia
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083242 Methods and compositions for treating or preventing peripheral neuropathies
05/01/2003US20030083229 Isolating T cells from mammal, incubating cells with protein expression product of activated oncogene or cancer-related gene associated with malignancy, detecting presence or absence of proliferation of T cells, determining malignancy
05/01/2003US20030082805 Methods for use of mpl ligands with primitive human stem cells
05/01/2003US20030082800 Expression vector for use in the generation of single stranded nucleotide sequences
05/01/2003US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents
05/01/2003US20030082747 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
05/01/2003US20030082740 Antitumor agent for use in the treatment of cancer
05/01/2003US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein
05/01/2003US20030082722 Method for amplifying expression from a cell specific promoter
05/01/2003US20030082685 Chemotherapeutic induction of egr-1 promoter activity
05/01/2003US20030082681 Nucleic acids, proteins, and antibodies
05/01/2003US20030082677 Nucleotide sequences coding polypeptide for use in the treatment of glucose transport defects
05/01/2003US20030082675 Expression vector for use as gene therapeutic tool
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082647 Transporter protein
05/01/2003US20030082620 Novel human genes and gene expression products: II
05/01/2003US20030082612 Detection of mutant leptin receptor; obtain cells, extract nucleotide sequences, incubate with an oligonucleotide probe, detect hybridization, presence of hybridization, indicates defective receptor
05/01/2003US20030082609 Nuceotide sequences coding polypeptide for use in humans therapeutics and diagnostics
05/01/2003US20030082599 Polynucleotide
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082527 Detecting preferential enzyme inhibitors; obtain cell extracts contain caspase, incubate with activator and test inhibitor, measure caspase activation, reduced caspase activation, indicates enzyme inhibitor
05/01/2003US20030082526 Diagnosis and treatment of cancer
05/01/2003US20030082515 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator
05/01/2003US20030082237 Binding to block polymer, polyelectrolytes; drug delivery, magnetism, optics, electronics
05/01/2003US20030082206 Method of preserving infectious recombinant viruses, aqueous viral suspension, and use as medicament
05/01/2003US20030082198 Administering complex of heat shock protein and antigen
05/01/2003US20030082197 Administering complex of heat shock protein and antigen
05/01/2003US20030082195 Method of enhancing an immune response
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082176 Therapy for metabolism disorders
05/01/2003US20030082169 System and method for the pretreatment of the endplates of an intervertebral disc
05/01/2003US20030082162 Therapy for genetic disorders in humans, animals; polypeptide coding antitrypsin
05/01/2003US20030082161 Efficient gene therapy; sustained release
05/01/2003US20030082160 Differentiation of whole bone marrow
05/01/2003US20030082159 Lentiviral vector-mediated gene transfer and uses thereof
05/01/2003US20030082158 Production of transduced hematopoietic progenitor cells
05/01/2003US20030082155 Antidiabetic agents; cell differentiation of stem cells
05/01/2003US20030082154 Fusogenic lipids and vesicles
05/01/2003US20030082152 Animal growth regulators; controlling cell differentiation; tissue engineering
05/01/2003US20030082150 Recombinant adenoviral vectors for human tumour gene therapy
05/01/2003US20030082145 Adeno-associated virus materials and methods
05/01/2003US20030082144 A viral nucleic acid construct for the high level expression of a heterologous protein in an insect cell; using baculovirus expression vector system for exogenous proteins production
05/01/2003US20030082143 Filamentous phage particles having a ligand on surface for delivering a therapeutic gene to a cell; gene therapy
05/01/2003US20030082142 Replication incompetent herpes viruses for use in gene therapy
05/01/2003US20030082141 COX-2 function and wound healing
05/01/2003US20030082140 Increasing the amount of the cell differentiation associated protein, MDA-7 and decreasing RAS gene activity by administering a viral vector comprising an MDA-7 gene and an antisense ras oligonucleotide; treating pancreatic cancer
05/01/2003US20030082139 Genetically modified human embryonic cells using a viral vector encoding an oncogene, can express active cytokines, chemokines, and other cytotoxic and neurotoxic substances; used for screening of compounds for diseases
05/01/2003US20030082137 Interleukin-3 gene therapy for cancer
05/01/2003CA2471532A1 A synthetic chimeric fusion protein with immuno-therapeutic uses
05/01/2003CA2464795A1 Thymosin augmentation of genetic immunization
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2464460A1 In vitro micro-organs, and uses related thereto
05/01/2003CA2464417A1 Promoters to control cell differentiation
05/01/2003CA2464394A1 Methods and compositions for inducing tumor-specific cytotoxicity
05/01/2003CA2464372A1 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003CA2464349A1 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2463772A1 Thrombin-cleavable chimeric proteins
04/2003
04/30/2003CN1414865A 癌症的治疗 Treatment of cancer
04/30/2003CN1414864A Adhesive particle DNA constructs and method of making and using the same
04/30/2003CN1414861A Induction of mucosal immunity by vaccination via skin nute
04/30/2003CN1107072C Programing cell death induced molecule II
04/30/2003CN1106846C Antitumor agent
04/29/2003US6555672 Growth differentiation factor promoter and uses therefor
04/29/2003US6555667 Hypoxia-regulated genes
04/29/2003US6555666 Transcripts encoding immunomodulatory polypeptides
04/29/2003US6555654 Low-density lipoprotein (LDL)-receptor related protein-3 (LRP-3); encoding nucleic acid; the gene is associated with type 1 diabetes (insulin dependent diabetes mellitus (IDDM); indications are it is the IDDM susceptibility gene IDDM4
04/29/2003US6555377 Process for production of mammalian cell lines
04/29/2003US6555370 Bifunctional selectable fusion genes
04/29/2003US6555368 Single-chain antibody introduced into the minor capsid proteins so that the adenoviral vector can be targeted to a particular cell type
04/29/2003US6555367 Complex of biotinylated viral vector and ligand for targeted gene delivery
04/29/2003US6555343 Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
04/29/2003US6555108 Implanting HSV-TK retrovirus producing cells to treat tumors
04/29/2003CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
04/24/2003WO2003033692A2 Use of the adenoviral e2 late promoter
04/24/2003WO2003033689A1 Cloning and recombinant expression of mammalian secreted group iif phopholipase a2
04/24/2003WO2003033668A2 Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis
04/24/2003WO2003033667A2 Use of mx gtpases in the prognosis and treatment of cancer
04/24/2003WO2003033657A2 Antisense antiviral agent and method for treating ssrna viral infection
04/24/2003WO2003033519A2 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
04/24/2003WO2003033514A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
1 ... 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 ... 870